Literature DB >> 5301644

Treatment of active toxoplasmic retino-choroiditis.

J Nolan, E S Rosen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5301644      PMCID： PMC506606          DOI： 10.1136/bjo.52.5.396

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Recurrence of treated toxoplasmic uveitis.

Authors:  C J CANAMUCIO; J W HALLETT; I H LEOPOLD
Journal:  Am J Ophthalmol       Date:  1963-05       Impact factor: 5.258

2.  CHEMOTHERAPY OF EXPERIMENTAL TOXOPLASMOSIS. EVALUATIONOF SPIRAMYCIN ALONE AND IN COMBINATION.

Authors:  C L GILES; L JACOBS; M L MELTON
Journal:  Arch Ophthalmol       Date:  1964-01

3.  THERAPY OF TOXOPLASMOSIS UVEITIS.

Authors:  M GHOSH; P M LEVY; I H LEOPOLD
Journal:  Am J Ophthalmol       Date:  1965-01       Impact factor: 5.258

4.  HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS.

Authors:  A TENPAS; J P ABRAHAM
Journal:  Am J Med Sci       Date:  1965-04       Impact factor: 2.378

5.  [Comparative effect of various synthetic agents and various antibiotics, including spiramycin, on Toxoplasma].

Authors:  J BOGACZ
Journal:  Bull Soc Pathol Exot Filiales       Date:  1954

6.  Treatment of toxoplasmosis uveitis.

Authors:  R V FAJARDO; F P FURGIUELE; I H LEOPOLD
Journal:  Arch Ophthalmol       Date:  1962-06

7.  A rational approach to the treatment of toxoplasmic uveitis.

Authors:  J K BEVERLEY
Journal:  Trans Ophthalmol Soc U K       Date:  1958

8.  [Spiramycin therapy of experimental toxoplasmosis in mice].

Authors:  J P GARIN; D E EYLES
Journal:  Presse Med       Date:  1958-05-28       Impact factor: 1.228

9.  The penetration of daraprim (pyrimethamine) into the monkey eye.

Authors:  H E KAUFMAN
Journal:  Am J Ophthalmol       Date:  1961-09       Impact factor: 5.258

10.  Relative resistance of slow-growing strains of Toxoplasma gondii to pyrimethamine (daraprim).

Authors:  H E KAUFMAN; J REMINGTON; M L MELTON; S L JACOB
Journal:  Arch Ophthalmol       Date:  1959-10
  10 in total
  4 in total

1.  Congenital ocular toxoplasmosis.

Authors:  D D Perry; J C Merritt
Journal:  J Natl Med Assoc       Date:  1983-02       Impact factor: 1.798

Review 2.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

Review 3.  Corticosteroids as adjuvant therapy for ocular toxoplasmosis.

Authors:  Smitha Jasper; Satyanarayana S Vedula; Sheeja S John; Saban Horo; Yasir J Sepah; Quan Dong Nguyen
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

Review 4.  Current treatment of toxoplasma retinochoroiditis: an evidence-based review.

Authors:  Meredith Harrell; Petros E Carvounis
Journal:  J Ophthalmol       Date:  2014-08-13       Impact factor: 1.909
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.